Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
ADMA Biologics: FY22 Numbers Key Inflection Point
01:29am, Sunday, 15'th Jan 2023
ADMA Biologics continues to outperform benchmarks, after offering investors a source of tactical alpha across the past 18 months. The market continues to reward its hypothesis in treating primary humo
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better
01:24pm, Tuesday, 10'th Jan 2023 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. I can not like binar
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
04:11pm, Saturday, 31'st Dec 2022 Benzinga
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
09:05pm, Friday, 09'th Dec 2022 GlobeNewswire Inc.
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 09, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicate
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
01:45pm, Wednesday, 07'th Dec 2022 GlobeNewswire Inc.
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicate
ADMA Biologics Announces Proposed Public Offering of Common Stock
09:05pm, Tuesday, 06'th Dec 2022 GlobeNewswire Inc.
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 06, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicat
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
09:01pm, Tuesday, 06'th Dec 2022 GlobeNewswire Inc.
Fourth Quarter 2022 Preliminary Estimated Total Revenues of Approximately $48-$50 Million Fourth Quarter 2022 Preliminary Estimated Total Revenues of Approximately $48-$50 Million
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
10:10am, Friday, 11'th Nov 2022 Benzinga
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 156.2% to close at $0.2608 on Thursday after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions relat
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
06:05pm, Thursday, 10'th Nov 2022 Benzinga
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's vo
Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
12:58pm, Thursday, 10'th Nov 2022 Benzinga
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11.
Coupang, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:28am, Thursday, 10'th Nov 2022 Benzinga
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Digital Turbine, Inc. (NASDAQ: APPS) jumped 21.4% to $13.07 in pre-ma
Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates
10:35pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Adma Biologics (ADMA) delivered earnings and revenue surprises of 0% and 18.86%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates
06:48pm, Wednesday, 09'th Nov 2022
Adma Biologics (ADMA) delivered earnings and revenue surprises of 0% and 18.86%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
11:00am, Wednesday, 02'nd Nov 2022 GlobeNewswire Inc.
Conference Call Scheduled for November 9, 2022, at 4:30 p.m. ET
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
07:00am, Wednesday, 02'nd Nov 2022
Conference Call Scheduled for November 9, 2022, at 4:30 p.m. ET
